| NDC Code | 63776-410-17 |
|---|
| Package Description | 250 mL in 1 BOTTLE (63776-410-17) |
|---|
| Product NDC | 63776-410 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Viatrexx-pigmentation |
|---|
| Non-Proprietary Name | Adrenal, Azelaic, Copper, Cutis, Cysteine, Epithelial Gf, Fumaric Acid, Glutathione, Glycolic Acid, Kalium Aspariticum, Lymph Node, Melanine, Natrum Oxalaceticum, Natrum Pyruvicum, Phenylalanine, Quinhydrone, Succinic Acid, Thuja, Tyrosine, Vitamin C, Zinc |
|---|
| Dosage Form | SPRAY |
|---|
| Usage | ORAL; TOPICAL |
|---|
| Start Marketing Date | 20190329 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | VIATREXX BIO INCORPORATED |
|---|
| Substance Name | ASCORBIC ACID; AZELAIC ACID; BOS TAURUS ADRENAL GLAND; BOS TAURUS LYMPH VESSEL; BOS TAURUS SKIN; COPPER; CYSTEINE; FUMARIC ACID; GLUTATHIONE; GLYCOLIC ACID; MELANIN SYNTHETIC (TYROSINE, PEROXIDE); NEPIDERMIN; PHENYLALANINE; POTASSIUM ASPARTATE; QUINHYDRONE; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUCCINIC ACID; SUS SCROFA ADRENAL GLAND; SUS SCROFA LYMPH VESSEL; SUS SCROFA SKIN; THUJA OCCIDENTALIS LEAFY TWIG; TYROSINE; ZINC |
|---|
| Strength | 30; 30; 30; 200; 30; 200; 30; 30; 200; 30; 200; 200; 200; 30; 30; 30; 30; 30; 30; 200; 30; 30; 30; 30 |
|---|
| Strength Unit | [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL |
|---|
| Pharmacy Classes | Allergens [CS], Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE], Decreased Sperm Motility [PE], Depigmenting Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Vitamin C [EPC] |
|---|